Erschienen in:
01.03.2008 | Poster presentation
Combination therapy with efungumab for the treatment of invasive Candida infections: several illustrative case reports
verfasst von:
P Spronk, B Van der Hoven, C Graham, F Jacobs, J Sterba, E Liakopoulou, A Qamruddin
Erschienen in:
Critical Care
|
Sonderheft 2/2008
Einloggen, um Zugang zu erhalten
Excerpt
Efungumab (Mycograb®) is a human recombinant antibody against fungal Hsp90 that, in combination with lipid-associated amphotericin B, has shown efficacy in patients with invasive candidiasis (phase 3 data). Eight compassionate-use case studies of efungumab in combination with antifungal agents in the treatment of invasive Candida infections are presented. …